Sydney Jennings

Your daily dose of the clinical news you may have missed.

Find details from the first study to forecast the multidimensional impact of chronic kidney disease, a study highlighting the widespread prevalence of cardiovascular-kidney-metabolic syndrome in the US, and more.

Your daily dose of the clinical news you may have missed.

ENDO 2024. New findings suggest GLP-1RAs and SGLT-2is may be more beneficial than other diabetes agents for patients with T2D and MASLD.

Your daily dose of the clinical news you may have missed.

ENDO 2024. The expert panel suggests children, pregnant persons, adults aged ≥75 years, and adults with prediabetes consume more vitamin D than the recommended daily allowance.

Your daily dose of the clinical news you may have missed.

The interactive tool provides clinicians and patients a real-time look at GLP-1RA availability.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Findings underscore a need for public health initiatives to educate vulnerable populations on cardiometabolic risks, researchers report.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

DDW 2024. An investigational blood-based screening test demonstrated nearly a 80% sensitivity for detecting CRC, according to a large prospective study.

Which state has the lowest percentage of teen drug users? Or the highest percentage of adults with unmet drug-treatment needs? Answers from a new report, here.

DDW 2024. Offspring with both parents with overweight had a nearly 3-fold increased risk of MASLD in young adulthood, according to new data.

Your daily dose of the clinical news you may have missed.

DDW 24. New research shows patients with MASLD and T2D who used GLP-1 agonists had a reduced risk of progression to cirrhosis and HCC vs non-users.

Your daily dose of the clinical news you may have missed.

Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.

New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.

Your daily dose of the clinical news you may have missed.

Find details on a novel web tool found to help patients determine their eligibility for OTC statin use, FDA clearance of the first AI-based algorithm to detect HF during routine exams, and more.

DDW 24. Among patients aged 15 to 19 years, the incidence of CRC rose 333% over a 22-year period, researchers reported.

Your daily dose of the clinical news you may have missed.

While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.

Your daily dose of the clinical news you may have missed.